欢迎来到 Bioassay Systems中国区代理商/公司/官网
全国咨询热线: 18771149750
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:15172469628

传真:18771997407

邮箱:sales@amyjet.com

新闻中心
AllerMAbs.jpg

艾乐美生物科技有限公司(AllerMAbs Co., Ltd.)成立于2015年,是台湾一家专注于生产高亲和力、高纯度并具有过敏原特异性的嵌合人类IgE单克隆抗体的生物公司。公司创办人团队在科研过程中发现市面上缺乏多样的IgE单克隆抗体,特別是具有过敏原特异性的人IgE 单抗。如果能制备出这种抗体,将有助于IgE 相关领域的研究工作。因此,AllerMAbs公司团队开始思考与研究利用基因克隆动物来制造人类 IgE 抗体的可行性,经过数年的努力于 2014年开发出人类IgE 抗体基因嵌入小鼠,通过杂交瘤技术 (Hybridoma technology),成功地研制出分泌嵌合人类IgE 单抗的 IgE 杂交瘤与纯化 IgE 抗体。经测试,此种嵌合人类IgE 单抗的物化性质与对免疫细胞的活性,皆与人类IgE 抗体一致,研究成果于2015 年发表在国际学术期刊上。

 

AllerMAbs的产品解决了目前人类IgE抗体不易制备的问题,让嵌合人类IgE抗体可以成为人类IgE抗体的替代品,并提供一个更稳定、更符合血清IgE检测系统的校正品,让临床血清IgE的检测结果更加准确与可靠。

 

其利用动物基因转殖技术,将组成人类IgE抗体分子的ε重链(Heavy chain)和κ轻链(Light chain)的编码基因(Encoding genes),分別嵌入(Knock-in)小鼠胚胎干细胞(Embryonic stem cells, ES cells)的γ1重链和κ轻链基因的位置,接着把胚胎干细胞分別植入孕母鼠体内,并将其带有嵌入基因之成鼠交互配种,最后得到带有人类IgE抗体重链和轻链基因的基因嵌入小鼠(HεκKI mice),且体内能制造完整的嵌合人类IgE抗体分子。

 

技术优势

容易制备IgE杂交瘤与IgE单抗

过敏原特异性

良好的亲和力与专一性

高纯度与高稳定性

可结合至嗜碱性粒细胞上的IgE受体与刺激細胞

可大量生产与高浓度制备

非人类血液来源(相较于血清IgE抗体)

适合用作检测用的校正品

" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="AllerMAbs">
AllerMAbs
...
阅读详情
Schircks Laboratories LOGO.jpg


艾美捷科技代理Schircks Laboratories品牌。

瑞士Schircks Laboratories由B.Schircks博士于1980年创立,主要生产蝶啶及蝶啶类化合物(Pteridines)。至今,Schircks实验室合成了100多种蝶啶类化合物,主要用于科学研究和临床诊断应用。产品包括:

<
11.1806-(L-1,2,3-Trihydroxybutyl)-pterin [Rhamnopterin]
11.182(6R,S)-5,6,7,8-Tetrahydro-L-rhamnopterin dihydrochloride
11.203L-Biopterin [L-erythro-Biopterin] 
11.2067,8-Dihydro-L-biopterin
11.209(6R,S)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride 
11.212(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride
11.213(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride
11.215(6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate
11.216(6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate
11.217(6R)-5-Methyl-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.218D-Biopterin [D-erythro-Biopterin]
11.220(6R,S)-5,6,7,8-Tetrahydro-D-biopterin dihydrochloride
11.221D-threo-Biopterin [Dictyopterin] 
11.223(6R,S)-5,6,7,8-Tetrahydro-D-threo-biopterin dihydrochloride 
11.228Deoxysepiapterin
11.2296-((1R,S)-Hydroxypropyl)pterin [(1'R,S)-2'-Deoxybiopterin]
11.2317-Biopterin 
11.2347-Tetrahydro-L-biopterin dihydrochloride
11.260Oncopterin
11.2704-Hydroxy-6-(L-erythro-1,2-dihydroxy-propyl)-2-(methylthio)pteridine
11.2804-Amino-L-biopterin [2,4-Diamino-6-(L-erythro-1',2'-dihydroxypropyl)pteridine]
11.2824-Amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.2834-Amino-(6R)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.303D-Neopterin [D-erythro-Neopterin] 
11.3067,8-Dihydro-D-neopterin  
11.3077,8-Dihydro-D-neopterin-3’-triphosphate  (Please refer to our reference 8)
11.309(6R,S)-5,6,7,8-Tetrahydro-D-neopterin dihydrochloride
11.314D-Neopterin-3’-monophosphate, lithium salt
11.3157,8-Dihydro-D-neopterin-3’-monophosphate, lithium salt  
11.3203'-Hydroxy-D-sepiapterin
11.3307-Neopterin  
11.340L-Monapterin [L-threo-Neopterin]
11.3457,8-Dihydro-L-monapterin
11.346(6R,S)-5,6,7,8-Tetrahydro-L-monapterin dihydrochloride
11.349D-Monapterin [D-threo-Neopterin]
11.403Pterin-6-carboxylic acid
11.409Pterin-7-carboxylic acid
11.4156-Formylpterin [Pterin-6-aldehyde]
11.4166-Formyl-7,8-dihydropterin
11.418Acetyl-6-formylpterin
11.4206-Hydroxymethylpterin
11.4216-Hydroxymethyl-7,8-dihydropterin hydrochloride
11.4226-Hydroxymethyl-7,8-dihydropterin-diphosphate    (Please refer to our reference 8)
11.423(6R,S)-6-Hydroxymethyl-5,6,7,8-tetrahydropterin dihydrochloride
11.4296-Hydroxymethylpterin-monophosphate 
11.4386-Hydroxymethylpterin-diphosphate, lithium salt  
11.4806-Methylpterin
11.4816-Methyl-7,8-dihydropterin hydrochloride
11.483(6R,S)-6-Methyl-5,6,7,8-tetrahydropterin dihydrochloride
11.5036,7-Dimethylpterin
11.5066,7-Dimethyl-7,8-dihydropterin monohydrochloride
11.5096,7-Dimethyl-5,6,7,8-tetrahydropterin monohydrochloride
11.703Leucopterin
11.713Xanthopterin
11.716Dihydroxanthopterin
11.723Isoxanthopterin
11.903Pterin
11.9067,8-Dihydropterin  (Please refer to our reference 20)
11.9095,6,7,8-Tetrahydropterin dihydrochloride
13.103Lumazine
13.2036-Hydroxylumazine
13.2066-Hydroxy-7,8-dihydrolumazine
13.2207-Hydroxylumazine
16.113Pteroic acid
16.123N10-(Trifluoroacetyl)pteroic acid
16.14010-Formylpteroic acid
16.203Folic acid  
16.2067,8-Dihydrofolic acid
16.208(6S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride  
16.209(6R,S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride 
16.21110-Methylfolic acid
16.21510-Formylfolic acid  
16.21710-Formyl-5,6,7,8-tetrahydrofolic acid  (Please refer to our reference 19)
16.220(6R,S)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt 
16.222(6R)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt (unnatural calcium folinate)  
16.230(6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic acid chloride
16.233(6R,S)-5-Methyl-5,6-dihydrofolic acid, ammonium salt  
16.235(6R,S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt
16.236(6S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt
16.243(6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid trihydrochloride
16.244(6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid trihydrochloride
16.252Pteroyldi-γ-L-glutamic acid  
16.253Pteroyltri-γ-L-glutamic acid   has been discontinued
16.254Pteroyltetra-γ-L-glutamic acid  
16.255Pteroylpenta-γ-L-glutamic acid  has been discontinued
16.266Pteroylhexa-γ-L-glutamic acid, ammonium salt
16.267Pteroylhepta-γ-L-glutamic acid, ammonium salt  
16.280(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroic acid
16.282(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyldi-γ-L-glutamic acid, lithium salt has been discontinued
16.283(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid, lithium salt has been discontinued
16.284(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid, lithium salt
16.285(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylpenta-γ-L-glutamic acid, lithium salt
16.286(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylhexa-γ-L-glutamic acid, lithium salt
16.330Aminopterin [4-Aminofolic acid]
16.4034-Amino-10-methylpteroic acid (APA, DAMPA)
16.411Methotrexate  [4-Amino-10-methylpteroyl-γ-L-glutamic acid]
16.4124-Amino-10-methylpteroyldi-γ-L-glutamic acid, ammonium salt [Methotrexate diglutamate]
16.4134-Amino-10-methylpteroyltri-γ-L-glutamic acid, ammonium salt [Methotrexate triglutamate] 
16.4144-Amino-10-methylpteroyltetra-γ-L-glutamic acid, ammonium salt [Methotrexate tetraglutamate] 
16.4154-Amino-10-methylpteroylpenta-γ-L-glutamic acid, ammonium salt [Methotrexate pentaglutamate]
16.4164-Amino-10-methylpteroylhexa-γ-L-glutamic acid, ammonium salt [Methotrexate hexaglutamate]
16.4174-Amino-10-methylpteroylhepta-γ-L-glutamic acid, ammonium salt [Methotrexate heptaglutamate] 
16.5007-Hydroxymethotrexate   
16.701p-Aminobenzoyl-L-glutamic acid
16.702p-Aminobenzoyldi-γ-L-glutamic acid, ammonium salt  
16.703p-Aminobenzoyltri-γ-L-glutamic acid, ammonium salt  
16.704p-Aminobenzoyltetra-γ-L-glutamic acid, ammonium salt  
16.705p-Aminobenzoylpenta-γ-L-glutamic acid, ammonium salt  
16.706p-Aminobenzoylhexa-γ-L-glutamic acid,  ammonium salt 
16.707p-Aminobenzoylhepta-γ-L-glutamic acid, ammonium salt  has been discontinued
16.901Z-Glu-OtBu
16.902Z-Glu2-OtBu3
16.903Z-Glu3-OtBu4  
16.904Z-Glu4-OtBu5  
16.905Z-Glu5-OtBu6  
16.906Z-Glu6-OtBu7  
91.303D-(5-15N)-Neopterin
96.203(5-15N)-Folic acid 
< " data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Schircks Laboratories品牌">
艾美捷科技代理Schircks Laboratories品牌
...
阅读详情
Logo-R-Website.pngexocell.jpg

艾美捷科技代理Ligatrap品牌全系列产品


LigaTrap Technologies是一家位于北卡罗来纳州的创新型生物技术公司,提供独特的专利技术组合,专注于蛋白质纯化领域。LigaTrap精于抗体与病毒纯化,服务于抗体药物、病毒疫苗及基因治疗产业。


LigaTrap公司产品

● LigaGuard:最新推出的亲和吸附剂,是由多模态配体构成的专利复合体系,可在流穿模式(连续流)下选择性捕获宿主细胞蛋白(HCPs)与DNA。

● AAVidity™:一种新型亲和层析填料,用于血清型普适性纯化 源自 HEK293 和 Sf9 细胞裂解液 的 腺相关病毒(AAV)。

● IgM Resin:专为纯化 IgM 抗体设计的亲和树脂,具有高纯度、高结合能力、温和的洗脱条件(pH 约 4.0),并可重复使用多达 100 次。

● Base Resin:专为从多克隆与单克隆来源中纯化高质量抗体而设计,该树脂推荐用于纯化:多种物种的 IgG(包括人、小鼠、兔等);人源 IgA;鸡源 IgY。

● LigaTrap Buffers:包含Regeneration Buffer,Neutralization Buffer,Elution Buffer,Regeneration Buffer,Equilibration/Wash Buffer 2.0等。


Ligatrap.png


LigaGuard

LigaGuard™树脂适用于两类核心产品的纯化:蛋白制品:单克隆抗体、生长因子;病毒制品:慢病毒、腺相关病毒(AAV)、病毒疫苗。该树脂的设计使目标生物产物无结合通过,实现高纯度与高回收率。其能清除传统纯化工艺难以去除的高残留性HCPs(HR-HCPs),显著提升终产物的纯度、稳定性、疗效与安全性。

品名货号规格
LigaTrap LigaGuard 1 ml Packed ColumnLT-LG1-1x1mL1mL
LigaTrap LigaGuard 5ml Packed ColumnLT-LG1-1x5mL5mL
LigaTrap LigaGuard Loose Resin - 5mLLT-LG15 mL
LigaTrap LigaGuard Loose Resin - 10mLLT-LG1-10mL10 mL
LigaTrap LigaGuard Loose Resin - 25mLLT-LG1-25mL25 mL
LigaTrap LigaGuard Loose Resin - 50mLLT-LG1-50mL50 mL
LigaTrap LigaGuard Loose Resin - 100mLLT-LG1-100mL100 mL


AAVidity

AAVidity填料通过合成亲和配体功能化修饰,可捕获所有血清型的 AAV,提供卓越的结合载量与污染物(宿主细胞蛋白 HCPs 及宿主细胞DNA hcDNA清除能力。其温和洗脱条件在保障 AAV 转导活性的同时,实现高产物回收率。

品名货号规格
LigaTrap AAVidity Loose Resin – 1mLLT-AAV-1mL1mL
LigaTrap AAVidity Loose Resin – 5mLLT-AAV-5mL5mL
LigaTrap AAVidity Prepacked Column – 1mLLT-AAV-1x1mL1x1mL
LigaTrap AAVidity Prepacked Column – 5mLLT-AAV-1x5mL1x5mL


▍IgM Resin

 IgM纯化树脂的核心优势包括:

● 全面捕获:同时结合IgM的重链与轻链亚型;

● 零风险:无免疫原性及配体脱落;

● 活性保全:温和洗脱条件保障抗体完整性;

● 经济耐用:消毒再生后可重复使用 ≥100 次;

● 该树脂能高效处理并纯化来自以下样本的单克隆 IgM:细胞培养上清,腹水,杂交瘤,其他重组 IgM 来源。

品名货号规格
IgM Microspin Column Kit w/ BuffersLT-155KITKIT-10x0.1mL
IgM 1mL Prepacked Column Kit w/ BuffersLT-155-1mL KITKIT-1x1mL
IgM 5mL Prepacked Column Kit w/ BuffersLT-155-5mL KITKIT-1x5mL
IgM Loose Resin – 5mLLT-1555mL
IgM Loose Resin – 10mLLT-155-10mL10mL
IgM Loose Resin – 25mLLT-155-25mL25mL
IgM Loose Resin – 50mLLT-155-50mL50mL
IgM Loose Resin – 100mLLT-155-100mL100mL
IgM Microspin Columns without BuffersLT-155-MSC10x0.1mL
IgM Prepacked Column – 1mLLT-155-1x1mL1x1mL
IgM Prepacked Column – 5mLLT-155-1x5mL1x5mL
IgM Prepacked Columns – 3x1mLLT-155-3x1mL3x1mL

▍Base Resin

LigaTrap基础纯化树脂可实现高回收率与>95%的纯度,而传统Protein A和Protein G填料的回收率甚至低于检测限。通过优化工艺,该树脂的纯度可进一步提升至99%。

品名货号规格
Base Resin Microspin Column Kit w/ BuffersLT-150KITKIT-10x0.1mL
Base Resin 1mL Prepacked Column Kit w/ BuffersLT-150-1mL KITKIT-1x1mL
Base Resin 5mL Prepacked Column Kit w/ BuffersLT-150-5mL KITKIT-1x5mL
Loose Base Resin – 5mLLT-1505mL
Loose Base Resin – 10mLLT-150-10mL10mL
Loose Base Resin – 25mLLT-150-25mL25mL
Loose Base Resin – 50mLLT-150-50mL50mL
Loose Base Resin – 100mLLT-150-100mL100mL
Base Resin Microspin Columns without BuffersLT-150-MSC10x0.1mL
Base Resin Prepacked Column – 1mLLT-150-1x1mL1x1mL
Base Resin Prepacked Column – 5mLLT-150-1x5mL1x5mL
Base Resin Prepacked Columns – 3x1mLLT-150-3x1mL3x1mL


▍Buffers

品名货号规格
LigaTrap Elution BufferBU-123-FP125ml
LigaTrap Regeneration BufferBU-124-FP50ml
LigaTrap Neutralization BufferBU-125-FP15ml
LigaTrap Storage BufferBU-126-FP50 ml
LigaTrap Sample Diluent 2.0BU-131-FP15 ml
LigaTrap Equilibration/Wash Buffer 2.0BU-132-FP250ml
LigaTrap IgM Elution Buffer pH 3.8BU-133-FP125 ml
LigaTrap Elution BufferBU-123-500-FP500ml
LigaTrap Regeneration BufferBU-124-500-FP500 ml
LigaTrap Neutralization BufferBU-125-250-FP250 ml
LigaTrap Storage BufferBU-126-500-FP500 ml
LigaTrap Sample Diluent 2.0BU-131-250-FP250 ml
LigaTrap Equilibration/Wash Buffer 2.0BU-132-1-FP1L
LigaTrap IgM Elution Buffer pH 3.8BU-133-500-FP500ml


" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Ligatrap品牌全系列产品">
艾美捷科技代理Ligatrap品牌全系列产品
...
阅读详情
艾美捷官网上传2.5:1.jpgexocell.jpg

艾美捷科技代理Rigaku Reagents品牌。

Rigaku Reagents 是 Rigaku 集团旗下的一家子公司,专注于为X射线晶体学领域提供高质量的化学试剂和工具。Rigaku 集团是全球知名的科学仪器制造商,尤其在X射线分析技术领域具有领先地位。Rigaku Reagents 的主要目标是支持科学家在蛋白质晶体学、材料科学和其他相关领域的研究,提供用于晶体生长、样品制备和分析的高质量试剂和耗材。热门产品包括:Wizard Classic/Wizard Cryo 系列蛋白结晶筛选试剂盒,结晶板,结晶工具,和 PEG3350、PEG6000、PEG8000 等试剂。主要产品类别为:

(1)晶体生长试剂:Rigaku Reagents 提供多种用于蛋白质和小分子晶体生长的试剂,包括结晶筛选试剂盒、缓冲液、沉淀剂和添加剂。这些试剂经过严格的质量控制,确保实验的可重复性和可靠性。

(2)结晶筛选试剂盒:公司提供多种结晶筛选试剂盒,如 Crystal Screen、Index Screen 和 SaltRx Screen,适用于不同类型的晶体生长实验。这些试剂盒设计科学,能够显著提高晶体生长的成功率。

(3)蛋白质结晶工具:提供用于蛋白质结晶的耗材和设备,如结晶板、密封膜和样品支架。这些工具与 Rigaku 的X射线衍射仪兼容,支持从晶体生长到数据分析的全流程。

(4)小分子结晶试剂:为小分子晶体学研究提供高质量的试剂和工具,支持药物开发、材料科学等领域的研究。

<<< " data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Rigaku Reagents品牌">
艾美捷科技代理Rigaku Reagents品牌
...
阅读详情
logo.jpg

<

艾美捷科技代理Helvetica Health Care品牌全系列产品


Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。


▎Helvetica Health Care产品线

Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。


HelveticaHealthCare页面.png


▎Helvetica Health Care部分产品列表


货号产品描述
NATFRC-6CNATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL)
NATCV9-6CNATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL)
NATRPC2.1-BIONATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)
NATRVP2.1-BIONATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA)
NATRVP2.1-BIO PlusNATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml)
NATRVP2-QIANATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA)
NATSARS(COV2)-VPNATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL)
NATSARS(COV2)-ERCSARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)
NATSARS(COV2)-ERC1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml)
NATSARS(COV2)-NEGSARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL)
NATSARS(COV2)-NEG1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml)
NATSARS(COV2)-STSARS-Related Coronavirus 2 (SARS-CoV-2) Stock
NATSARS(COV2-SA)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)
NATSARS(COV2-UK)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL)
0810229-0.5mgCoronavirus 229E Lysate (0.5 mg)
0810587SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg)
0810587-0.5mgSARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg)
0810587CFHI-0.5mLSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL)
0810587CFHISARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL)
0810587UVSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL)
0810589CFHISARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL)
0810589UVSARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL)
0810590CFHISARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810590UVSARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL)
0810617UVSARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV))
0810618UVSARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV)
0810619UVSARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810620UVSARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810621UVSARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated)
0810622UVSARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated)
0810612CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810612UVSARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL)
0810613CFHISARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL)
0810613UVSARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL)
0810614CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810614UVSARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL)
0810616CFHISARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL)
0810616UVSARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL)
0810617CFHISARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml)
0810618CFHISARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml)
0810619CFHISARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810620CFHISARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810621CFHISARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml)
0810622CFHISARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml)
0810623UVSARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated)
0810623CFHISARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated)
0810624UVSARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated)
0810624CFHISARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated)
0820010CFHIVeroE6 Culture Fluid (Heat Inactivated) (1 mL)
0801043Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml)
0831042SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL)
0831043SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL)
NATSARS-STCoronavirus SARS Stock (Qualitative) (1 mL)
NATCOV(229E)-STCoronavirus 229E Stock (Qualitative) (1 mL)
0810229CFHICoronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL)
0810229Coronavirus Strain: 229E Lysate
0810229UVCoronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(NL63)-STCoronavirus NL63 Stock (Qualitative) (1 mL)
0810228CFHICoronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL)
0810228Coronavirus Strain: NL63 Lysate
0810228UVCoronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(OC43)-STCoronavirus OC43 Stock (Qualitative) (1 mL)
0810024CFHICoronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL)
0810024Coronavirus Strain: OC43 Lysate
NATMERS-STMERS-CoV Stock (Qualitative) (1 mL)
NATMR-BIONATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml)
NATCOV(MR)-BIONATtrol MERS-S. Cerevisiae (0.6 ml)
0810575MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg)
0810575-0.5mgMERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg)
CV033122COVID-19 Cross Over Panel (40x 1.0 ml)




" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Helvetica Health Care品牌全系列产品">
艾美捷科技代理Helvetica Health Care品牌全系列产品
...
阅读详情

城市分站
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:13212737804

传真:18995651644

邮箱:sales@amyjet.com

0.3707

Copyright © 2026 Powered by Bioassay Systems中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap